Figure 5

Kaplan Meier (KM) Analysis of olanzapine versus aripiprazole for days to loss of response, where loss of response was defined as a ≥ 20% worsening of PANSS _1–7 Total score and a CGI-S score ≥ 3 in patients who had a ≥ 20% improvement over baseline PANSS _1–7 Total score at Week 8. There was no significant difference between treatment groups for time remaining in aripiprazole (p = .97).